The Food and Drug Administration has sent Pathway Genomics a warning letter that expresses concern over its new liquid biopsy test for cancer, and that it’s being marketed with a direct-to-consumer ...

Taking advantage of last year’s Supreme Court ruling against many gene patents, Pathway Genomics Corp. said Tuesday it has started selling a test to detect mutation in genes associated with breast ...

Walgreens has postponed its plans to sell an over-the-counter genetic test due to FDA concerns that "consumers are putting themselves at risk if they use a test not approved" by the federal agency.

SAN DIEGO, CA – June 3, 2014 – Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, today announced it has ...

Thanks to breakthroughs in technology, the market for genetic tests that give patients information about their genes has surged over the past decade. According to one recent estimate, there are now ...

Direct-to-consumer genetic testmaker Pathway Genomics is the first to market in launching a liquid biopsy test that screens for multiple cancers. That means that from a single blood test it will be ...

Pathway Genomics reeled in $40 million in Series E financing to spur development of its genetic tests, funds that will come in handy as the company sets its sights on international growth and moves ...

The Pathway Fit genetic test from San Diego based Pathway Genomics is designed to help people tailor their exercise and diet based on their DNA. So basically it claims to be able to tell you whether ...

“We have [...] examined published literature and have not found any published evidence that this test or any similar test has been clinically validated as a screening tool for early detection of ...